Search

Search Results

• Dare voce ai pazienti nella ricerca sulle malattie rare e sui famaci orfani / Giving patients a voice in the rare diseases and orphan drugs research

  Elena Mancini, Roberta Martina Zagarella

  25-40

  23-03-2018

  https://doi.org/10.4081/mem.2018.526

  859

  PDF (Italian): 14

• Una pillola per diventare più buoni? Il dibattito sul "moral bioenhancement" / A pill to become better people? The debate on "moral bioenhancement"

  Francesco Paolo Adorno

  131-153

  21-09-2016

  https://doi.org/10.4081/mem.2016.431

  996

  PDF (Italian): 6

• Clinical and ethical use of induced pluripotent stem cells / Uso clinico ed etico delle cellule pluripotenti indotte

  Jaime Millás-Mur

  291-305

  30-07-2018

  https://doi.org/10.4081/mem.2018.540

  1067

  PDF (Italian): 7

• La figura del biostatistico nei Comitati Etici (CE). Linee guida per il ruolo del biostatistico e per l'attività del biostatistico nella revisione dei protocolli degli studi proposti al parere dei CE / The figure of biostatistician for Ethics Committees (ECs). Guidelines for the role of biostatistician and for the activity of biostatistician in the review of research protocols proposed for ECs

  Bruno Mario Cesana, Elio Mario Briganzoli

  567-588

  23-11-2016

  https://doi.org/10.4081/mem.2016.454

  859

  PDF (Italian): 6

• Ethical principles in prescribing drugs to elderly patients

  F. Cavazzuti, R. Nardi, C. D'Anastasio

  637-665

  31-08-1994

  https://doi.org/10.4081/mem.1994.1006

  194

  PDF (Italian): 0

• "Unsustainable drugs" and intergenerational healthcare justice

  Pietro Refolo, Dario Sacchini, Filippo Rumi, Americo Cicchetti, Antonio G. Spagnolo

  411-422

  20-12-2019

  https://doi.org/10.4081/mem.2019.596

  762

  PDF (Italian): 27

• Oltre il visibile Le nanotecnologie e la nanomedicina: definizioni e problematiche bioetiche

  Antonio G. Spagnolo, Viviana Daloiso

  30-06-2008

  https://doi.org/10.4081/mem.2008.280

  778

  PDF (Italian): 1

• Ulipristal acetate. An emergency contraceptive?

  Justo Aznar, Julio Tudela

  30-04-2011

  https://doi.org/10.4081/mem.2011.170

  833

  PDF (Italian): 3

• Studio pilota sui problemi etici emergenti fra i medici di base in Italia

  Vittoradolfo Tambone, Gaetano Piccinocchi, Massimiliano Andrea Vitali

  30-04-2013

  https://doi.org/10.4081/mem.2013.101

  778

  PDF (Italian): 2

• L'utilizzo del placebo secondo l'ultima versione della Dichiarazione di Helsinki. Dibattito fra due posizioni etiche

  Fabrizio Liborio, Pablo Requena Meana

  28-02-2015

  https://doi.org/10.4081/mem.2015.33

  1343

  PDF (Italian): 6

• The human experimentation of new drugs: research on the consent of the subject

  Daniele Rodriguez, Lorenzo Meloni, Cinzia Lavagnolo

  789-818

  31-12-1991

  https://doi.org/10.4081/mem.1991.1122

  175

  PDF (Italian): 0

• Il dibattito in Bioetica - I nuovi farmaci per l'HCV: una possibile "lezione metodologica" / The debate in Bioethics. The new drugs for HCV: a possible "methodological lesson"

  Dario Sacchini

  533-537

  11-10-2017

  https://doi.org/10.4081/mem.2017.505

  871

  PDF (Italian): 20

• Pain Therapy.

  Giovanni Del Missier, Laura Colautti

  255-260

  30-04-2002

  https://doi.org/10.4081/mem.2002.700

  216

  PDF (Italian): 1

• The availability of the body

  Roberto Mordacci

  491-509

  30-06-1994

  https://doi.org/10.4081/mem.1994.1017

  141

  PDF (Italian): 0

• Clinical trials of drugs: Current state of the regulatory problem and proposals for reform

  Adriano Bompiani

  14-10-2024

  https://doi.org/10.4081/mem.1982.1529

  93

  PDF: 0

• Too sick for drugs. Too knotty for principles. Scientific research, ethics and cinema

  Paolo Marino Cattorini

  141-164

  30-06-2019

  https://doi.org/10.4081/mem.2019.579

  629

  PDF: 10

• The fight against drugs. Can Switzerland serve as an example? Perspectives of comparative epidemiology

  Giovanni Fantacci, Michael G. Koch

  909-936

  31-10-2000

  https://doi.org/10.4081/mem.2000.770

  240

  PDF (Italian): 3

• Human rights and bioethical indications in the prescription of psychotropic drugs

  Elio Sgreccia

  20-01-1989

  https://doi.org/10.4081/mem.1989.1265

  112

  PDF: 1

• Fetal pain.

  Carlo Valerio Bellieni

  1081-1089

  31-12-2002

  https://doi.org/10.4081/mem.2002.681

  205

  PDF (Italian): 0

• Pastoral health care and some of medicine's social responsibilities

  Leonardo Antico

  515-523

  30-06-1990

  https://doi.org/10.4081/mem.1990.1177

  182

  PDF (Italian): 0

• Family and drugs: considerations of a sociologist

  Silvano Burgalassi

  15-10-2024

  https://doi.org/10.4081/mem.1981.1552

  114

  PDF: 3

• The psychological consequences of voluntary abortion: the data of some researches.

  Claudia Genovese

  711-729

  31-08-2002

  https://doi.org/10.4081/mem.2002.690

  276

  PDF (Italian): 0

• Drug <>

  Leonardo Ancona

  15-10-2024

  https://doi.org/10.4081/mem.1981.1550

  103

  PDF: 3

• The psychological outcome and ethical and assistance implications for heart transplant subjects

  Antonio Puca

  87-97

  28-02-1992

  https://doi.org/10.4081/mem.1992.1116

  209

  PDF (Italian): 0

• The doctor and drugs. Regulatory provisions, medical-legal aspects, deontological problems

  Paolo Benciolini

  15-10-2024

  https://doi.org/10.4081/mem.1981.1549

  115

  PDF: 2

• Norlevo and conscience objection.

  M.L. Di Pietro, M. Casini, A. Fiori, R. Minacori, L. Romano, A. Bompiani

  411-455

  30-06-2003

  https://doi.org/10.4081/mem.2003.666

  400

  PDF (Italian): 1

• Specific receptor drugs in the therapeutic strategy of opioid addiction

  Paolo Preziosi

  15-10-2024

  https://doi.org/10.4081/mem.1981.1548

  105

  PDF: 2